This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Exubera, The Inhaled Insulin Passes FDA

Posted: Friday, March 18, 2005

The companies want to provide Exubera to adult patients with type 1 (the most serious) and type 2 diabetes, a joint statement said.

Exubera is currently also under review by the European Medicines Evaluation Agency.

The treatment has been tested on more than 3,400 patients, some for more than seven years, the statement said. "It is estimated that nearly 180 million people worldwide suffer from diabetes, and the number is expected to rise to 300 million people in the next 20 years," it added.

Diabetes and associated complications cost more than USD 100 million (EUR 75 million) per year in the US, the drug companies said.

Source: Diabetes In Control.com.